The National Health Council (NHC) appreciates the opportunity to provide comments on the Centers for Medicare and Medicaid Services’ (CMS) proposed rule on the Benefit and Payment Parameters for 2022 […]
Letters + Comments
Integrated Assessment of Marketing Applications Virtual Workshop
The Honorable Stephen Hahn Commissioner U.S. Food and Drug Administration Food and Drug Administration Dear Commissioner Hahn: On behalf of the National Health Council (NHC), I am pleased to provide the following comments […]
HHS Securing Updated and Necessary Statutory Evaluations Timely
The National Health Council (NHC) appreciates the opportunity to provide comments on the Department of Health and Human Services’ (HHS) proposed rule on creating a system of regular review of […]
Patient-Centered Outcomes Research Institute (PCORI) Proposed Principles Comment Letter
The National Health Council (NHC) appreciates the opportunity to provide comments on the Patient-Centered Outcomes Research Institute (PCORI) Proposed Principles for the Consideration of the Full Range of Outcomes Data. […]
Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary
Medicare Coverage of Innovative Technology (MCIT) Pathway We applaud CMS for creating the Medicare Coverage of Innovative Technology (MCIT) pathway to accelerate the coverage of new, innovative breakthrough devices for […]
Medicare Program: Hospital Outpatient Prospective Payment Comment Letter
The National Health Council (NHC) appreciates the opportunity to provide comments on the Centers for Medicare and Medicaid Services’ (CMS) request for comments on the Hospital Outpatient Prospective Payment System. […]
Centers for Medicare & Medicaid Services’ (CMS) Medicare Physician Fee Schedule
CMS-1734-P: CY 2021 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Medicaid Promoting Interoperability Program Requirements for Eligible […]
Office of Women’s Health Strategic Priorities; Establishment of a Public Docket; Request for Comments
The National Health Council (NHC) appreciates the opportunity to provide comments as the Food and Drug Administration’s (FDA’s) establishes its Office of Women’s Health (OWH) Strategic Priorities public docket. The […]
Reauthorization of the Prescription Drug User Fee Act
The National Health Council (NHC) appreciates the opportunity to provide a response to the Food and Drug Administration’s (FDA’s) request for comments on the next cycle of the Prescription Drug […]
Centers for Medicare & Medicaid Proposed Rule on Value-Based Purchasing Arrangement
The National Health Council (NHC) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) proposed rule to facilitate the adoption of value-based purchasing (VBP) arrangements, […]